Clinical Trials

Pituitary Adenoma, Familial Isolated, Acromegaly, Gigantism

NCT03665064 2026-03-16

Long Term Outcome Study in Patients With Pituitary Disorders

Active not recruiting

1,500 enrolled

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma

NCT07306325 2025-12-29

Ultrasound in Predicting Difficult Intubation in Acromegaly Patients

Not yet recruiting

34 enrolled

EndocrineGastrointestinalNET

Acromegaly, Growth Hormone-Secreting Pituitary Adenoma

NCT05364944 2025-11-17

OXTEND-01

Phase 1 Terminated

19 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT07179926 2025-09-18

Pasi-Bone

Recruiting

120 enrolled

Acromegaly, Growth Hormone-Secreting Pituitary Adenoma

NCT01809808 2025-08-26

A Prospective Study of Outcome After Therapy for Acromegaly

280 enrolled

Acromegaly, Pituitary Neoplasms

NCT06253897 2024-12-24

BackSOM

EndocrineGastrointestinalNET

20 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

DermatologicEndocrineGenitourinaryNET

337 enrolled 8 charts

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT06326853 2024-06-11

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Not yet recruiting

200 enrolled

EndocrineOther

Acromegaly, Cushing Syndrome, Endocrine System Diseases, Hypopituitarism, Obesity, Pituitary Neoplasms

NCT02419664 2022-03-31

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours

Phase 3 Terminated

22 enrolled

Acromegaly, Pituitary Diseases, Pituitary Neoplasms

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

NCT00446082 2020-12-21

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Phase 1 Completed

85 enrolled

Acromegaly, Carcinoid Tumor

NCT00001981 2020-11-27

The Treatment and Natural History of Acromegaly

117 enrolled

Acromegaly, Pituitary Neoplasms

NCT04529356 2020-08-27

The TMS Treatment for Postoperative Headache in GH Tumor

Phase NA Unknown

200 enrolled

Acromegaly, Headache, Pituitary Neoplasms

NCT03474601 2020-03-18

SNU-PIT

1,600 enrolled

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma, Diabetes Insipidus, Neurogenic, Pituitary ACTH Hypersecretion

NCT02354508 2019-12-10

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Phase 3 Completed

123 enrolled 27 charts

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01673646 2019-09-16

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

Phase 2 Completed

33 enrolled 24 charts

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01840449 2019-01-14

SOPRANo

156 enrolled

EndocrineNET

Acromegaly, Neuroendocrine Tumors

NCT01504399 2018-08-22

Rhinological Outcomes in Endonasal Pituitary Surgery

235 enrolled

Acromegaly, Adrenocortical Hyperfunction, Pituitary Neoplasms, Prolactinoma

NCT01137682 2018-04-05

PAOLA

Phase 3 Completed

198 enrolled 17 charts

Acromegaly, Pituitary Neoplasms

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

90 enrolled

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

20 enrolled

CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT00171886 2017-02-24

Octreotide Efficacy and Safety in First-line Acromegalic Patients

20 enrolled

Acromegaly

NCT02854228 2016-08-03

PITUICARE-Lyon

1,300 enrolled

Acromegaly, Pituitary Neoplasms, Prolactinoma

NCT01568359 2014-12-05

Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors

49 enrolled

Acromegaly

NCT01029275 2014-07-31

SAPORO

Phase NA Completed

89 enrolled

Acromegaly, Pituitary Neoplasms

NCT01368133 2013-09-26

The Observational Study of Growth Hormone-secreting Pituitary Tumors

60 enrolled

Acromegaly, Pituitary Neoplasms

NCT00598949 2010-12-15

Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

600 enrolled

Acromegaly, Adenoma, Neoplasms, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma

NCT00001860 2008-03-04

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Phase 2 Completed

5 enrolled

Acromegaly, Pituitary Neoplasms

NCT00017927 2008-03-04

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

Phase 3 Completed

10 enrolled

Acromegaly, Adenoma, Fibrous Dysplasia, Polyostotic, Hyperplasia

NCT00627796 2008-03-03

ATG1line

27 enrolled

Acromegaly, Neoplasms

NCT00616408 2008-02-15

Prediction of Tumor Shrinkage in Acromegaly

61 enrolled

Acromegaly

NCT00461149 2007-04-17

HDacro

50 enrolled